Clinical Trial

Association Between SYNTAX Score and Leukoglycemic Index In Patients Wiht Acute Coronary Syndrome

Completed
View on ClinicalTrials.gov →
Summary
This study looks at people who come to the hospital with acute coronary syndrome, a serious heart condition. When these patients first arrive, doctors take routine blood tests. The investigators use these test results to calculate a value called the leukoglycemic index (LGI), which combines white blood cell count and blood sugar level. The investigators also use a heart imaging score called the SYNTAX score to see how complex their coronary artery disease is. Patients are divided into two groups based on their SYNTAX scores: one group with lower scores (22 or less), and one with higher scores (above 22). The investigators compare their health data to see if LGI is linked to the severity of their heart disease. The investigators also check if LGI can help predict how complex the disease is. Information like age, family history, and chronic illnesses is collected from patient records and medical interviews.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Trial Details
NCT Number NCT07276256
Lead Sponsor Kırıkkale University
Conditions Acute Coronary Syndromes (ACS)
Enrollment 552 participants
Start Date 2025-09-24
Primary Completion 2025-10-21 (estimated)
Study Completion 2025-10-21 (estimated)
Updated on ClinicalTrials.gov 2026-02-25